-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FHzNmB74RuFhvS3Ro79LmUMnpq/l5jR2AkZ3VBD9Kd7WtzwO/8bthza3vzo/T4oY SGxwv/YRGWgm6LtPrQqQIw== 0001179110-07-014770.txt : 20070712 0001179110-07-014770.hdr.sgml : 20070712 20070712131329 ACCESSION NUMBER: 0001179110-07-014770 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070710 FILED AS OF DATE: 20070712 DATE AS OF CHANGE: 20070712 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES INC CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARTIN JOHN C CENTRAL INDEX KEY: 0001190578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 07975985 BUSINESS ADDRESS: BUSINESS PHONE: 650-574-3000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DRIVE CITY: FOSTER CITY STATE: X1 ZIP: 94404 4 1 edgar.xml FORM 4 - X0202 4 2007-07-10 0 0000882095 GILEAD SCIENCES INC GILD 0001190578 MARTIN JOHN C 333 LAKESIDE DRIVE FOSTER CITY CA 94404 1 1 0 0 President and CEO Common Stock 2007-07-10 4 M 0 70000 1.4297 A 1546049 D Common Stock 2007-07-10 4 S 0 20000 39.65 D 1526049 D Common Stock 2007-07-10 4 S 0 15000 39.6528 D 1511049 D Common Stock 2007-07-10 4 S 0 15000 39.6505 D 1496049 D Common Stock 2007-07-10 4 S 0 10000 39.6522 D 1486049 D Common Stock 2007-07-10 4 S 0 10000 39.6867 D 1476049 D Non-Qualified Stock Option (right to buy) 1.4297 2007-07-10 4 M 0 70000 0 D 2008-07-22 Common Stock 70000 140784 D The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan established by Dr. Martin on August 29, 2006. All shares and dollar amounts reflect a two-for-one split that was effected on June 22, 2007 benefiting all shareholders of record as of May 24, 2007. Amount of securities beneficially owned following the reported transactions includes 791 shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan on June 29, 2007. The options vested 20% on July 23, 1999, the first anniversary date of the grant. The balance vested 5% every three months thereafter and was fully vested as of July 23, 2003. /s/Gregg Alton, by Power of Attorney for John C. Martin 2007-07-10 -----END PRIVACY-ENHANCED MESSAGE-----